Department of Urology, Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium.
ORSI Academy, Gent, Belgium.
Prostate Cancer Prostatic Dis. 2024 Mar;27(1):122-128. doi: 10.1038/s41391-023-00726-7. Epub 2023 Sep 29.
Robot-Assisted Simple Prostatectomy (RASP) has emerged as a promising alternative in the treatment of benign prostatic obstruction (BPO). However, there is currently a lack of comparative studies evaluating different robotic platforms for performing RASP. Therefore, we aimed to compare perioperative and functional outcomes of RASP performed using the HUGO™ RAS System versus the DaVinci® Xi System.
Forty consecutive cases of RASP performed between May 2021 and March 2023 with the HUGO™ RAS and the DaVinci® Xi at OLV Hospital (Aalst, Belgium) were included in this retrospective study. All surgeries were performed by three experienced surgeons using the same approach. Baseline characteristics, peri-operative and functional outcomes were collected and compared between the two groups.
The population was equally divided between the two groups with 20 patients in each group. There were no significant differences in preoperative patient characteristics between the two groups, except for the presence of bladder stones prior to the surgery (p = 0.03). No significant differences in total operative time and console time between the two groups were reported (p = 0.3). No cases required conversion to open surgery or additional port placement. During one case performed with the HUGO™ RAS, a malfunctioning monopolar curved shear had to be replaced. However, there was no statistically significant differences in terms of technical robotic problems between the groups (p = 0.3). There was no significant difference between the two groups in perioperative and functional outcomes (all p ≥ 0.2).
We did not observe any statistically significant difference in perioperative and functional outcomes in case of RASP performed with the HUGO™ RAS System and with the DaVinci® Xi System. These findings provide compelling support for considering the HUGO™ RAS as a promising tool for robot-assisted procedures, thereby expanding the utilization of robotics for benign conditions.
机器人辅助简单前列腺切除术(RASP)作为治疗良性前列腺梗阻(BPO)的一种有前途的替代方法已经出现。然而,目前缺乏评估用于执行 RASP 的不同机器人平台的比较研究。因此,我们旨在比较使用 HUGO™ RAS 系统与 DaVinci® Xi 系统进行 RASP 的围手术期和功能结果。
本回顾性研究纳入了 2021 年 5 月至 2023 年 3 月期间在 OLV 医院(比利时阿尔斯特)使用 HUGO™ RAS 和 DaVinci® Xi 进行的 40 例连续 RASP 病例。所有手术均由三名经验丰富的外科医生使用相同的方法进行。收集并比较了两组患者的基线特征、围手术期和功能结果。
两组患者的人口分布均等,每组 20 例。两组患者的术前患者特征无显著差异,除手术前存在膀胱结石外(p=0.03)。两组患者的总手术时间和控制台时间无显著差异(p=0.3)。无病例需要转为开放手术或额外放置端口。在使用 HUGO™ RAS 进行的一个病例中,必须更换功能失调的单极弯曲剪切器。然而,两组之间在机器人技术问题方面没有统计学上的显著差异(p=0.3)。两组在围手术期和功能结果方面无显著差异(所有 p≥0.2)。
我们没有观察到使用 HUGO™ RAS 系统和 DaVinci® Xi 系统进行 RASP 的围手术期和功能结果有任何统计学上的显著差异。这些发现为考虑将 HUGO™ RAS 作为机器人辅助手术的有前途的工具提供了有力支持,从而扩大了机器人技术在良性疾病中的应用。